Slide 1: Interim Management Statement
Interim Management Statement 1 3 T H N OV E M B E R 2 0 1 2 A L B E RT M A N I F O L D M Y L ES L E E M A E V E C A RTO N CO O C EO FD
Slide 2: Agenda
1 Agenda 2012 TRADING AND OUTLOOK COST REDUCTION MEASURES WRAP UP CRH Interim Management Statement, 13th November 2012
Slide 3: 2012 Trading and Outlook
2 2012 T RADING AND O UTLOOK CRH Interim Management Statement, 13th November 2012
Slide 4: YTD (Sept) 2012: Sales +4%; EBITDA in line with 2011
3 YTD (Sept) 2012: Sales +4%; EBITDA in line with 2011 Like for like sales changes v. 2011 Europe Americas Group H1 ‐5% +8% +1% Q3 ‐7% +1% ‐3% YTD ‐6% +5% ‐1% Q3 overall Sales up +1%; YTD September up +4% Q3 EBITDA maintained at €0.65Bn (2011: €0.65Bn) YTD September EBITDA €1.2Bn; (2011: €1.
Slide 5: 2012 Europe Outlook
4 2012 Europe Outlook EBITDA Indications Materials Products Distribution Total c10% Up to 25% c15% c15% 2012 Change decrease decrease decrease decrease 2011 Actual €436m €194m €267m €0.90Bn Materials: Absence of Secil contribution; lower CO2 benefits Products: Continuing impact of Eurozone crisi
Slide 6: 2012 Americas Outlook
5 2012 Americas Outlook EBITDA Indications Materials Products Distribution Total c10‐15% c5% Broadly in 2012 Change Slightly lower increase increase line 2011 Actual $738m $228m $90m $1.06Bn Materials: Weaker second‐half volumes as expected, plus Q4 storm effects Products: Benefiting from reside
Slide 7: 2012 Outlook Non-trading
6 2012 Outlook Non‐trading Depreciation & Share of Associates Net Finance Amortisation* Disposal Profits PAT* Costs 2012 Similar >€200m Lower +10% Outlook 2011 Actual €764m €55m €53m €257m Reported first‐half profits of €183m on business divestments First‐half share of associates* €12m (2011:€23
Slide 8: 2012 Outlook: Expect Full Year EBITDA of c€1.6 Bn
7 2012 Outlook: Expect Full Year EBITDA of c€1.6 Bn Profit before tax Profit before tax EBITDA (before impairment) (after impairment) 2012 Low to mid‐single c.€1.6Bn Lower Outlook digit % increase 2011 €1.65Bn €743m €711m Actual With strong disposal profits, PBT before impairment will be ahead of
Slide 9: YTD (Nov) 2012: Acquisition spend c€0.4 Bn
8 YTD (Nov) 2012: Acquisition spend c€0.4 Bn €Bn H1 2012 H2 to‐date Year‐to‐Date Europe / Asia 0.17 0.06 0.23 Americas 0.08 0.08 0.16 Total 0.25 0.14 0.39 13 bolt‐ons to our Materials Platforms, and 1 investment in Yatai concrete 12 bolt‐ons across our Products and Distribution businesses … Acti
Slide 10: Cost Reduction Measures
9 C OST R EDUCTION M EASURES CRH Interim Management Statement, 13th November 2012
Slide 11: 2012-2015 Focus on Costs
10 2012‐2015 Focus on Costs Short‐term economic challenges… particularly in Europe Continuing to roll out cost reduction programmes… Adding to €2Bn savings achieved 2007‐2011… €450m incremental savings in 2012‐2015 covering… o Structural o Process o Procurement … Continuing to proactively ma
Slide 12: Cumulative 2012 – 2015 Planned Cost Reductions
11 Cumulative 2012 – 2015 Planned Cost Reductions … €450m incremental savings … … over 70% expected to be permanent in nature … CRH Interim Management Statement, 13th November 2012
Slide 13: Further Reductions Targeted 2012-2015
12 Further Reductions Targeted 2012‐2015 Savings • Admin rationalisation and back office pooling Structural €180m • Reorganisation of production footprint • Further reductions in manning levels • Increased usage of alternative fuels Process €180m • Higher level of RAP usage • Improved operational th
Slide 14: Wrap Up
13 W RAP UP CRH Interim Management Statement, 13th November 2012
Slide 15: Summary
14 Summary Cost Savings Action Balance Sheet Optimising our cost base and Expect year‐end improving our effectiveness net debt/EBITDA below 2x Development Capital Market Days Continuing good flow of London 16th November 2012 development opportunities New York 19th November 2012 CRH Interim Managemen
Slide 16: Contact Us
15 Contact Us CRH plc. Investor Relations Belgard Castle Clondalkin Dublin 22 Ireland Phone: + 353 1 404 1000 Fax: + 353 1 404 1007 Email: ir@crh.com This presentation contains certain forward‐looking statements as defined under US legislation. By their Website: www.crh.com nature, such statements i